Michael Fisch

7.9k total citations
186 papers, 5.3k citations indexed

About

Michael Fisch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Fisch has authored 186 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Fisch's work include Cancer survivorship and care (39 papers), Cancer Treatment and Pharmacology (31 papers) and Economic and Financial Impacts of Cancer (23 papers). Michael Fisch is often cited by papers focused on Cancer survivorship and care (39 papers), Cancer Treatment and Pharmacology (31 papers) and Economic and Financial Impacts of Cancer (23 papers). Michael Fisch collaborates with scholars based in United States, Canada and United Kingdom. Michael Fisch's co-authors include Charles S. Cleeland, Éduardo Bruera, Fengmin Zhao, David Cella, Benny G. Johnson, Tito R. Mendoza, Ann M. O’Mara, J. Lynn Palmer, Barry M. Farr and Victor T. Chang and has published in prestigious journals such as JAMA, The Journal of Chemical Physics and Journal of Clinical Oncology.

In The Last Decade

Michael Fisch

180 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fisch United States 35 2.3k 1.2k 1.2k 903 564 186 5.3k
Winnie K.W. So Hong Kong 34 1.9k 0.8× 743 0.6× 816 0.7× 646 0.7× 155 0.3× 213 4.3k
M L Slevin United Kingdom 38 1.8k 0.8× 626 0.5× 785 0.7× 628 0.7× 416 0.7× 106 4.9k
Jennifer J. Griggs United States 51 4.7k 2.1× 933 0.8× 1.5k 1.3× 1.4k 1.6× 275 0.5× 232 9.3k
Gary B. Chisholm United States 38 1.8k 0.8× 1.3k 1.1× 2.3k 2.0× 555 0.6× 386 0.7× 123 6.0k
L. Lee Dupuis Canada 39 1.6k 0.7× 2.6k 2.1× 1.2k 1.0× 534 0.6× 310 0.5× 216 6.0k
S. Kaasa Norway 49 4.0k 1.7× 2.4k 2.0× 1.9k 1.6× 2.0k 2.2× 965 1.7× 116 8.3k
Tenbroeck Smith United States 30 2.9k 1.2× 1.1k 0.9× 1.0k 0.9× 1.0k 1.1× 91 0.2× 52 5.3k
Christina Bougatsos United States 33 985 0.4× 536 0.4× 1.7k 1.5× 530 0.6× 782 1.4× 106 6.2k
Massimo Costantini Italy 44 1.6k 0.7× 1.3k 1.0× 3.2k 2.7× 644 0.7× 329 0.6× 184 6.1k
Richard T. Penson United States 48 5.2k 2.2× 620 0.5× 650 0.6× 1.3k 1.4× 136 0.2× 241 10.6k

Countries citing papers authored by Michael Fisch

Since Specialization
Citations

This map shows the geographic impact of Michael Fisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fisch more than expected).

Fields of papers citing papers by Michael Fisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fisch. The network helps show where Michael Fisch may publish in the future.

Co-authorship network of co-authors of Michael Fisch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fisch. A scholar is included among the top collaborators of Michael Fisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fisch. Michael Fisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullangi, Samyukta, Benjamin Ukert, David Debono, et al.. (2024). Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members. Journal of Clinical Oncology. 43(2). 133–142. 1 indexed citations
2.
Stearns, Vered, Opeyemi A. Jegede, Victor T. Chang, et al.. (2024). A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical Cancer Research. 30(13). 2709–2718. 4 indexed citations
3.
Sedhom, Ramy, Jill Feldman, Ronit Elk, et al.. (2024). Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision Medicine. American Society of Clinical Oncology Educational Book. 44(3). e434026–e434026. 3 indexed citations
4.
Gordon, Aliza S., et al.. (2023). Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score <50%. Cancer Treatment and Research Communications. 37. 100769–100769. 1 indexed citations
5.
Liu, Ying, Samyukta Mullangi, David Debono, et al.. (2023). Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors. JCO Oncology Practice. 19(9). 731–740. 1 indexed citations
6.
Vaidya, Riha, Amy K. Darke, Krishna S. Gunturu, et al.. (2023). Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).. JCO Oncology Practice. 19(11_suppl). 368–368. 1 indexed citations
7.
Freeman‐Daily, Janet, Michael Fisch, Emil Lou, et al.. (2022). The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator. JCO Oncology Practice. 18(8). 578–583. 23 indexed citations
8.
Kanter, Genevieve P., Ravi B. Parikh, Michael Fisch, et al.. (2022). Trends in Medically Integrated Dispensing Among Oncology Practices. JCO Oncology Practice. 18(10). e1672–e1682. 5 indexed citations
9.
Henry, N. Lynn, Joseph M. Unger, Cathee Till, et al.. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum. 5(6). 2 indexed citations
10.
Stephenson, Judith J., Rebekah Zincavage, Gregory L. Price, et al.. (2021). Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study. Patient Preference and Adherence. Volume 15. 2417–2429. 5 indexed citations
11.
Pompe, Raisa S., Felix Preißer, Sami‐Ramzi Leyh‐Bannurah, et al.. (2020). Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer. European Urology Open Science. 19. e1892–e1892. 1 indexed citations
12.
Bekelman, Justin E., Atul Gupta, Ezra Fishman, et al.. (2020). Association Between a National Insurer’s Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending. Journal of Clinical Oncology. 38(34). 4055–4063. 7 indexed citations
13.
Fisch, Michael, Michael Grabner, Daniel S. Mytelka, et al.. (2020). <p>Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer</p>. Cancer Management and Research. Volume 12. 1535–1541. 1 indexed citations
14.
Fishman, Ezra, John Barron, Ying Liu, et al.. (2019). <p>Using claims data to attribute patients with breast, lung, or colorectal cancer to prescribing oncologists</p>. PubMed. Volume 10. 15–22. 8 indexed citations
15.
Shen, Sherry, Joseph M. Unger, Katherine D. Crew, et al.. (2018). Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. 172(3). 603–610. 33 indexed citations
16.
Kern, David M., John J. Barron, Bingcao Wu, et al.. (2017). A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data. PubMed. Volume 8. 149–155. 13 indexed citations
17.
Fisch, Michael. (2011). Werke und Freuden : Michel Foucault-eine Biographie. 1 indexed citations
18.
Reyes‐Gibby, Cielito C., Xifeng Wu, Margaret R. Spitz, et al.. (2008). Molecular epidemiology, cancer-related symptoms, and cytokines pathway. The Lancet Oncology. 9(8). 777–785. 77 indexed citations
19.
Fisch, Michael & Allen W. Burton. (2007). Cancer pain management. 3 indexed citations
20.
Burton, Allen W., et al.. (2007). Chronic Pain in the Cancer Survivor: A New Frontier. Pain Medicine. 8(2). 189–198. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Winnie K.W. So Breakdown of academic impact, for papers by M L Slevin Breakdown of academic impact, for papers by Jennifer J. Griggs Breakdown of academic impact, for papers by Gary B. Chisholm Breakdown of academic impact, for papers by L. Lee Dupuis Breakdown of academic impact, for papers by S. Kaasa Breakdown of academic impact, for papers by Tenbroeck Smith Breakdown of academic impact, for papers by Christina Bougatsos Breakdown of academic impact, for papers by Massimo Costantini Breakdown of academic impact, for papers by Richard T. Penson
Rankless by CCL
2026